From management:
The pertinent points are:
No more
From management:
The pertinent points are:
No more S-1 filings under our GHS Equity Line of Credit, which stops the immediate dilution caused by that financing arrangement. We cancelled it our $15,000,000 Equity Line of Credit with GHS.
Under our new agreement, GHS purchases Preferred Stock, converts it to Common, and has a total 6 month holding period on their investment. This will give the Company breathing room to allow the stock upward mobility.
We had to increase our authorized to accommodate for the Reserve Requirements in the new GHS agreement (set aside in Treasury, doesn’t go into the market). While doing so, we created some headroom so we have the ability to pursue potential acquisitions. The pertinent point is that NONE of the increase goes into the market at this time.
It’s hard to glean those points from the filings.
Paul K.
9
1
Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Neo Pepe Coin: Breaking Ground in the Cryptocurrency World Neo Pepe Coin ($NEOP), an emergent player in the cryptocurrency landscape, has been making waves as it progresses through multiple presale stages. This new digital currency is not only attracting crypto enthusiasts but also garnering interest from larger investors or 'whales' looking for promising opportunities. A...
Continue Reading
Upcoming Conference Call for Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) has recently announced an upcoming conference call dedicated to discussing its financial results for the first quarter of fiscal year 2025. This important event is set for a morning slot to ensure that all stakeholders can participate and gain insights into the company's performance. Details of...
Continue Reading
Modella AI's PathChat DX Achieves Breakthrough Device Designation BOSTON -- Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is excited to announce that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This remarkable recognition...
Continue Reading
Nicholas Wealth Announces New Distribution Rate for FIAX ETF Nicholas Wealth, a well-respected player in the actively managed income exchange-traded funds (ETFs) space, has revealed an exciting increase in the distribution rate for the Nicholas Fixed Income Alternative ETF (FIAX) to 8.04%. This significant change underscores their dedication to delivering strong returns...
Continue Reading
Understanding Total Voting Rights in Investment Firms Investors often seek clarity regarding their holdings, and a key aspect of this is understanding total voting rights and share capital. Recently, significant information was disclosed by Hargreave Hale AIM VCT PLC, and it’s worth exploring what this means. Company Overview Hargreave Hale AIM VCT PLC stands out in the...
Continue Reading